Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

MRNA

Moderna Inc

Sep 11 • 04:00PM ET

25.39

+1.08 4.44 %

Healthcare • Biotechnology • USA • NASD

Peers: BNTX NVAX REGN ALNY INCY BMRN SRPT VRTX GILD BIIB

| Held by: VTI VB VOO VBR RSP XBI SPY IVV XLV IBB

Scroll to Statements

Index	S&P 500	P/E	-	EPS (ttm)	-7.52	Insider Own	11.70%	Shs Outstand	389.00M	Perf Week	4.57%
Market Cap	9.88B	Forward P/E	-	EPS next Y	-7.51	Insider Trans	-0.00%	Shs Float	343.56M	Perf Month	-1.05%
Enterprise Value	5.49B	PEG	-	EPS next Q	-2.05	Inst Own	73.78%	Short Float	17.42%	Perf Quarter	-8.50%
Income	-2903.00M	P/S	3.21	EPS this Y	-4.03%	Inst Trans	3.07%	Short Ratio	6.35	Perf Half Y	-27.48%
Sales	3.08B	P/B	1.05	EPS next Y	22.16%	ROA	-20.97%	Short Interest	59.84M	Perf YTD	-38.94%
Book/sh	24.16	P/C	1.92	EPS next 5Y	18.81%	ROE	-27.50%	52W High	79.88 -68.21%	Perf Year	-66.86%
Cash/sh	13.19	P/FCF	-	EPS past 3/5Y	- -42.94%	ROIC	-28.75%	52W Low	23.15 9.68%	Perf 3Y	-80.48%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-43.99% 121.86%	Gross Margin	45.74%	Volatility	4.70% 4.41%	Perf 5Y	-60.84%
Dividend TTM	-	EV/Sales	1.78	EPS Y/Y TTM	51.07%	Oper. Margin	-106.34%	ATR (14)	1.23	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.77	Sales Y/Y TTM	-38.95%	Profit Margin	-94.31%	RSI (14)	45.83	Recom	2.85
Dividend Gr. 3/5Y	- -	Current Ratio	3.93	EPS Q/Q	36.16%	SMA20	-0.69%	Beta	2.01	Target Price	43.37
Payout	-	Debt/Eq	0.08	Sales Q/Q	-41.08%	SMA50	-11.24%	Rel Volume	1.25	Prev Close	24.31
Employees	5800	LT Debt/Eq	0.07	Earnings	Aug 01 BMO	SMA200	-19.96%	Avg Volume	9.43M	Price	25.39
IPO	Dec 07, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	28.75% 28.16%	Trades		Volume	11,765,055	Change	4.44%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-13-25	Initiated	Citigroup	Neutral	$40
Feb-18-25	Downgrade	Barclays	Overweight → Equal Weight	$111 → $45
Jan-29-25	Downgrade	Goldman	Buy → Neutral	$99 → $51
Dec-18-24	Downgrade	Argus	Buy → Hold
Dec-10-24	Resumed	BofA Securities	Underperform	$41
Nov-19-24	Initiated	Berenberg	Hold	$42
Nov-18-24	Upgrade	HSBC Securities	Hold → Buy	$58
Nov-15-24	Initiated	Wolfe Research	Underperform	$40
Oct-17-24	Initiated	Bernstein	Mkt Perform	$55
Sep-13-24	Downgrade	Oppenheimer	Outperform → Perform
Sep-13-24	Downgrade	JP Morgan	Neutral → Underweight	$88 → $70
Sep-13-24	Downgrade	Jefferies	Buy → Hold	$120 → $65
Aug-28-24	Upgrade	HSBC Securities	Reduce → Hold	$82
Aug-07-24	Upgrade	Deutsche Bank	Sell → Hold	$85 → $80
Aug-05-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$125 → $90
Feb-26-24	Downgrade	HSBC Securities	Hold → Reduce	$75 → $86
Jan-02-24	Upgrade	Oppenheimer	Perform → Outperform	$142
Nov-29-23	Initiated	Canaccord Genuity	Hold	$82
Nov-03-23	Upgrade	HSBC Securities	Reduce → Hold	$89 → $69
Nov-02-23	Downgrade	Deutsche Bank	Hold → Sell	$125 → $60

Show Previous Ratings

Today 03:00AM	Pfizer Is Growing More Reliant on Vaccines as Controversies Swirl (Barrons.com)
Sep-11-25 08:06AM	Which Investments Do the Uber-Rich Favor? This Wall Street Pro Knows. (Barrons.com)
10:05AM	Merck Falls 14% YTD: Time to Buy, Sell or Hold the Stock? (Zacks)
Sep-10-25 04:00AM	Pharmas new boomtown? Why drugmakers are setting up shop in a small Swiss city. (Pharma Voice)
Sep-09-25 08:00PM	Health Officials Hunt for Cases Connecting Covid Shot and Harm in Pregnant Women (The Wall Street Journal)
02:26PM	Loading…
Sep-08-25 02:26PM	Why Moderna (MRNA) Shares Are Falling Today (StockStory)
01:41PM	Amid Vaccine Controversy, Pfizer Says New Covid Shots Are Effective (Barrons.com)
Sep-07-25 02:28PM	I Thought Of Moderna, Inc. (MRNA) After Florida's Vaccine Rules, Says Jim Cramer (Insider Monkey)
04:42AM	Is it Time to Dump Your Shares of Moderna? (Motley Fool)
Sep-05-25 11:33AM	Analyst Report: Moderna, Inc. (Morningstar Research)
10:27AM	Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.? (Investor's Business Daily)
Sep-04-25 12:44AM	1 Cash-Heavy Stock Worth Your Attention and 2 We Question (StockStory)
Sep-03-25 03:08PM	Analyst Report: Moderna, Inc. (Morningstar Research)
Sep-02-25 07:00AM	Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism (ACCESSWIRE)
04:57AM	Is Moderna Stock Underperforming the S&P 500? (Barchart)
01:34AM	Loading…
01:34AM	Moderna (MRNA) Gains FDA Nod for Next-Gen COVID-19 Vaccine Targeting LP.8.1 Variant (Insider Monkey)
12:33AM	3 Healthcare Stocks with Warning Signs (StockStory)
Aug-31-25 08:40AM	Large-cap biotech is a sector to watch for investors: Analysts (Yahoo Finance)
Aug-29-25 11:51AM	Boyd Gaming and Shoe Carnival have been highlighted as Zacks Bull and Bear of the Day (Zacks)
Aug-28-25 12:04PM	FDA Approves Updated COVID-19 Vaccines but With Restrictions (Zacks)
07:55AM	FDA approves mRNA vaccines for new Covid-19 season amid political tension (Pharmaceutical Technology)
04:56AM	Moderna, Inc. (MRNA) Expands Into Oncology with Pan-Tumor Vaccine (Insider Monkey)
03:49AM	Analyst Report: Moderna, Inc. (Morningstar Research)
Aug-27-25 11:32PM	Reflecting On Therapeutics Stocks' Q2 Earnings: Moderna (NASDAQ:MRNA) (StockStory)
04:27PM	RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles. (Investor's Business Daily)
03:05PM	Why Moderna (MRNA) Stock Is Up Today (StockStory)
01:56PM	FDA Approves Pfizer Covid Vaccine but Adds Restrictions on Its Use (Barrons.com)
01:42PM	New Covid-19 Boosters Are Coming Soon. Not Everyone Will Be Eligible to Get One. (The Wall Street Journal)
01:24PM	Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2 (ACCESSWIRE)
Aug-26-25 08:31PM	Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months' (Benzinga)
10:30AM	Loading…
Aug-25-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) -6.53%
08:10AM	Modernas updated Covid-19 vaccine gets Canadian approval (Pharmaceutical Technology)
Aug-24-25 02:17AM	Moderna, Inc. (MRNA) Down 35% YTD. Here Is Why (Insider Monkey)
Aug-22-25 06:02PM	Moderna Stock Jumps After Canada Approves New Covid Vaccine (GuruFocus.com) -6.53%
09:25AM	Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1 (ACCESSWIRE)
Aug-21-25 07:00AM	Moderna to Present at Upcoming Conferences in September 2025 (ACCESSWIRE)
Aug-20-25 04:23PM	Covid-19 Vaccine Guidelines Are Changing. What We Know About Who Can Get a Shot. (Barrons.com)
Aug-19-25 09:06AM	Can Keytruda Sustain Merck's Growth Through the Rest of 2025? (Zacks)
Aug-18-25 03:58AM	Biopharma layoffs rise as drugmakers tighten belts and reorganize (Pharma Voice)
Aug-17-25 09:30AM	If You're in Your 30s, Consider Buying These 2 Healthcare Stocks (Motley Fool)
Aug-14-25 09:00AM	U.S. mRNA Therapeutics CDMO Market to Hit Valuation of US$ 6.27 Billion by 2033 \| Astute Analytica (GlobeNewswire)
Aug-13-25 03:16PM	Moderna Stock Jumps as NIH Chief Tempers Administration's Attack on mRNA (Barrons.com)
07:30AM	[Latest] Global AI in Synthetic Biology Market Size/Share Worth USD 192.95 Billion by 2034 at a 28.63% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)
12:18AM	3 Reasons to Avoid MRNA and 1 Stock to Buy Instead (StockStory)
12:15AM	The 5 Most Interesting Analyst Questions From Moderna's Q2 Earnings Call (StockStory)
12:04AM	MRNA Q2 Deep Dive: Revenue Beat Overshadowed by Lower Guidance and Cost Cuts (StockStory)
Aug-12-25 02:20PM	Moderna, Teleflex, Envista, Enovis, and UnitedHealth Shares Are Soaring, What You Need To Know (StockStory)
Aug-11-25 09:17AM	Merck Stock Down 4% Since Q2 Results: How to Play the Stock (Zacks)
07:36AM	mRNA Platform Strategic Business Analysis Report 2025 \| Global Market to Reach $129.1 Billion by 2030 - Rising Infectious Diseases, Technological Advancements, and Pandemic Preparedness Drive Growth (GlobeNewswire)
05:22AM	The 3 Things That Matter for Moderna Now (Motley Fool)
Aug-09-25 06:35PM	Moderna, Inc. (MRNA)'s "Got The Double Whammy," Says Jim Cramer (Insider Monkey)
Aug-07-25 03:17PM	Moderna Is Cutting 10,000 Jobs as Its Business Erodes. How Should You Play MRNA Stock Here? (Barchart)
10:16AM	Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma (GlobeNewswire)
07:34AM	RFK Jrs mRNA funding halt signals shift in US public health (Pharmaceutical Technology)
04:31AM	AI is already upending the corporate org chart as it flattens the distance between the C-suite and everyone else (Fortune)
Aug-06-25 06:22PM	Podcast: Stock Indexes Rise as Trump Boosts India Tariffs; Earnings in Focus (The Wall Street Journal)
03:27PM	RFK Jr. Ordered the HHS to Stop Funding mRNA Vaccine Development. The Edict Hit a Biotech Working on an Unrelated Treatment. (Barrons.com)
02:19PM	Moderna's stock takes a hit as RFK Jr. backs out of some mRNA vaccine deals (MarketWatch)
08:08AM	Novavax beats quarterly revenue estimates on milestone payment (Reuters)
03:35AM	Moderna Stock: Is Wall Street Bullish or Bearish? (Barchart)
Aug-05-25 06:52PM	HHS to Wind Down mRNA Vaccine Programs (The Wall Street Journal)
06:00AM	Lipid Nanoparticles Market Industry Trends, Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2034 (GlobeNewswire)
04:03AM	Cancer Vaccine Research Report 2025-2035 \| Market Accelerates with Key Players Like Merck and Moderna, Backed by Pharma-Biotech Collaborations and Academic Partnerships (GlobeNewswire)
Aug-04-25 05:07PM	Health Care Roundup: Market Talk (The Wall Street Journal)
Aug-02-25 03:05AM	Moderna Inc (MRNA) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Cost ... (GuruFocus.com)
Aug-01-25 06:00PM	Here's What Key Metrics Tell Us About Moderna (MRNA) Q2 Earnings (Zacks) -6.61%
05:08PM	Stocks Sink as Bonds Jump on Deepening Jobs Cracks: Markets Wrap (Bloomberg)
04:10PM	Moderna Cuts Forecast, Stock Wobbles Despite Beat (GuruFocus.com)
03:47PM	What Companies Have Said About Jobs in the Past Quarter (The Wall Street Journal)
02:14PM	Moderna sharpens focus on $1.5bn cost cutting plan after 41% revenue slump (Pharmaceutical Technology)
01:21PM	MRNA Beats on Q2 Earnings & Sales, Stock Down on Lowered Sales View (Zacks)
12:59PM	Analyst Report: Moderna, Inc. (Morningstar Research)
12:20PM	Why Moderna (MRNA) Stock Is Trading Lower Today (StockStory)
11:38AM	These Stocks Are Moving the Most Today: Apple, Amazon, Figma, Fluor, Eastman Chemical, MicroStrategy, Coinbase, and More (Barrons.com)
10:33AM	Moderna Stock Is Falling After Earnings. What Has Wall Street Worried. (Barrons.com)
10:30AM	Moderna Stock Drops as Firm Cuts Revenue Outlook on UK Vaccine Deliveries Delay (Investopedia)
09:46AM	Coinbase, ExxonMobil & Chevron, Moderna: Trending Tickers (Yahoo Finance Video)
08:44AM	Moderna's Key Patent Win Overshadowed By Gloomy Outlook (Benzinga)
08:10AM	Moderna (MRNA) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
08:06AM	Earnings live: Exxon, Chevron profits beat estimates, Moderna stock tumbles (Yahoo Finance)
08:06AM	Earnings live: Exxon, Chevron oil output boosts profits, Moderna stock tumbles (Yahoo Finance)
08:06AM	Earnings live: Exxon, Chevron oil output boosts profits, Moderna stock tumbles, Amazon sinks (Yahoo Finance)
07:46AM	Moderna lowers top end of revenue guidance as vaccine group targets cost cuts (Investing.com)
07:43AM	Moderna Stock Dives After Earnings Report. What Has Wall Street Worried. (Barrons.com)
07:32AM	Moderna Stock Falls Again Amid Lowered Guidance, Job Cuts (Investor's Business Daily)
07:28AM	Moderna (NASDAQ:MRNA) Exceeds Q2 Expectations But Stock Drops (StockStory)
07:10AM	Moderna Logs Sales Beat Despite Declining Vaccine Demand (The Wall Street Journal)
07:08AM	Moderna quarterly sales beat Street estimates on COVID booster sales, cost cuts (Reuters)
07:07AM	Moderna: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Moderna Reports Second Quarter 2025 Financial Results and Provides Business Updates (ACCESSWIRE)
06:19AM	Chevron and Exxon Mobil head earnings for Friday (MarketWatch)
06:00AM	UK Court of Appeal Confirms Moderna's EP'949 Patent is Valid and Infringed by Pfizer/BioNTech (ACCESSWIRE)
Jul-31-25 06:15PM	Tariff deadline, jobs report, Exxon earnings: What to Watch (Yahoo Finance Video) -8.06%
05:47PM	Moderna plans to slash 10% of workforce as COVID shot sales slow (Fox Business)
04:45PM	Moderna to Report Earnings Amid Shrinking Cash Balance. Investors Want to See If It Can Stop the Bleeding. (Barrons.com)
12:33PM	Health Care Roundup: Market Talk (The Wall Street Journal)
11:06AM	Nvidia, eBay, Moderna: Trending Tickers (Yahoo Finance Video)
09:14AM	More than 800 Moderna employees will lose their jobs this year as costs are slashed (MarketWatch)
08:10AM	Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Top Estimates (Zacks)
07:27AM	Moderna to lay off 10% of workforce in difficult but necessary step (BioPharma Dive)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hussain Abbas	Director	Jun 11 '25	Sale	28.00	312	8,736	580	Jun 12 04:22 PM
Hussain Abbas	Director	Jun 11 '25	Proposed Sale	28.00	312	8,736		Jun 11 10:06 AM
Bancel Stephane	Chief Executive Officer	Mar 03 '25	Buy	31.22	160,314	5,004,318	9,210,686	Mar 04 04:27 PM
SAGAN PAUL	Director	Mar 03 '25	Buy	31.76	31,620	1,004,251	312,027	Mar 04 04:24 PM
Klinger Shannon Thyme	Chief Legal Officer	Dec 09 '24	Sale	44.68	529	23,637	20,446	Dec 10 04:08 PM
Klinger Shannon Thyme	Officer	Dec 09 '24	Proposed Sale	44.68	529	23,637		Dec 09 03:18 PM
Klinger Shannon Thyme	Chief Legal Officer	Dec 03 '24	Sale	43.30	112	4,849	19,837	Dec 04 05:11 PM
Hoge Stephen	President	Dec 03 '24	Sale	43.30	314	13,595	1,443,904	Dec 04 05:08 PM
Klinger Shannon Thyme	Officer	Dec 03 '24	Proposed Sale	43.30	112	4,849		Dec 03 04:11 PM
Hoge Stephen	Officer	Dec 03 '24	Proposed Sale	43.30	314	13,595		Dec 03 03:23 PM
Mock James M	Chief Financial Officer	Nov 29 '24	Sale	42.79	1,420	60,761	11,066	Dec 02 04:26 PM
Klinger Shannon Thyme	Chief Legal Officer	Nov 29 '24	Sale	42.79	1,418	60,675	19,717	Dec 02 04:19 PM
Hoge Stephen	President	Nov 29 '24	Sale	42.79	291	12,452	1,443,567	Dec 02 04:15 PM
Hoge Stephen	Officer	Nov 29 '24	Proposed Sale	42.79	291	12,452		Nov 29 03:54 PM
Klinger Shannon Thyme	Officer	Nov 29 '24	Proposed Sale	42.79	1,418	60,675		Nov 29 03:49 PM
Mock James M	Officer	Nov 29 '24	Proposed Sale	42.79	1,420	60,761		Nov 29 03:35 PM
Hoge Stephen	President	Nov 11 '24	Sale	46.10	277	12,771	1,443,248	Nov 12 04:14 PM
Hoge Stephen	Officer	Nov 11 '24	Proposed Sale	46.10	277	12,771		Nov 12 09:27 AM
Mock James M	Chief Financial Officer	Oct 07 '24	Sale	60.12	715	42,986	9,505	Oct 08 04:19 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRNA

Moderna Inc

Upgrade your FINVIZ experience